Using CNV profiles for more than 40,000 individuals with or without schizophrenia, researchers got a refined look at gains and losses linked to the condition.
In Genome Biology this week: single-cell transcriptomic study of embryonic stem cell differentiation, epigenome-wide association study of schizophrenia, and more.
Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.
Through their combined genetic and epigenetic study of schizophrenia, the researchers have generated a list of genes affected by risk factors for the disease.
They found that hippocampal long-term potentiation triggered changes in protein signaling, including to a number of proteins linked to these disorders.
Data from 43 genome-wide association studies have led researchers to individual variants and genetic factors that influence multiple phenotypes and conditions.
A University of Pittsburgh research team used a novel computational approach to uncover the protein interactions, which may be potential treatment targets.
Researchers have found nearly 175 genomic loci that are differentially methylated in people with schizophrenia.
In Nature this week: analysis of nuclear DNA from ancient hominin, epigenetic influence on obesity, and more.
Researchers link loss-of-function mutations in the methyltransferase-encoding SETD1A to schizophrenia risk.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.